首页> 外文会议>Hemophilie-Symposion >Progression of an Extensive Deep Vein Thrombosis under High Dose Therapy with low Molecular Weight Heparln of a 13-Year-OId Girl Suffering from Colitis Ulcerosa

【24h】

Progression of an Extensive Deep Vein Thrombosis under High Dose Therapy with low Molecular Weight Heparln of a 13-Year-OId Girl Suffering from Colitis Ulcerosa

机译：高剂量疗法下大量静脉血栓形成的进展，低分子肝炎患有血小霉素的13岁女孩患者

获取原文

页面导航

摘要
著录项
相似文献
相关主题

摘要

Patients suffering from inflammatory bowel disease (IBD) are known to have a threefold higher risk for thrombotic events compared to standard population. Recent studies show no higher prevalence for genetic thrombophilic risk factors in this group. Compared to patients without IBD manifestation of thrombosis appears earlier in life. Changed coagulation situation during inflammation is suspected to be the major cause. However it is clear that there must be multifactorial genesis.

机译：已知患有炎症性肠病（IBD）的患者与标准群体相比，血栓形成事件的风险具有三倍。最近的研究表明该组遗传血栓性危险因素的患病率较高。与没有IBD的患者相比，血栓形成的表现出现在生活中早期。怀疑在炎症期间改变了凝结情况是主要原因。但很明显，必须有多重创造的创世纪。

著录项

来源
《Hemophilie-Symposion》|2004年||共2页
会议地点
作者
M. Deml; C. Bidlingmaier; H.-Erhardt; Th. Lang; U. Nowak-Gottl; K. Kurnik;
展开▼
作者单位

展开▼
会议组织
原文格式 PDF
正文语种
中图分类出血性疾病;
关键词

相似文献

外文文献
中文文献
专利

1. A fixed-dose combination of low molecular weight heparin with dihydroergotamine versus adjusted-dose unfractionated heparin in the prevention of deep-vein thrombosis after total hip replacement. [J] . Horbach T, Wolf H, Michaelis HC, Thrombosis and Haemostasis: Journal of the International Society on Thrombosis and Haemostasis . 1996,第2期

机译：低分子量肝素与二氢麦角胺的固定剂量组合与调整剂量的普通肝素预防全髋关节置换术后深静脉血栓形成的预防。
2. Reduction in thrombus extension and clinical end points in patients after initial treatment for deep vein thrombosis with the fixed-dose body weight-independent low molecular weight heparin certoparin. [J] . Harenberg J, Huisman MV, Tolle AR, Seminars in Thrombosis and Hemostasis . 2001,第5期

机译：固定剂量体重独立的低分子量肝素抗癌蛋白对深静脉血栓形成的初始治疗后，患者血栓扩展和临床终点的减少。
3. Prophylaxis of catheter-related deep vein thrombosis in cancer patients with low-dose warfarin, low molecular weight heparin, or control: A randomized, controlled, phase III study [J] . Lavau-DenesS., LacroixP., MaubonA., Cancer chemotherapy and pharmacology. . 2013,第1期

机译：低剂量华法令，低分子量肝素或对照的癌症患者预防导管相关的深静脉血栓形成：一项随机，对照的III期研究
4. Progression of an Extensive Deep Vein Thrombosis under High Dose Therapy with low Molecular Weight Heparln of a 13-Year-OId Girl Suffering from Colitis Ulcerosa [C] . M. Deml, C. Bidlingmaier, H.-Erhardt, Hemophilie-Symposion . 2004

机译：高剂量疗法下大量静脉血栓形成的进展，低分子肝炎患有血小霉素的13岁女孩患者
5. Histotripsy as an Adjuvant Therapy for Deep Vein Thrombosis [D] . Hendley, Samuel Anderson. 2021

机译：组蛋白酶作为深静脉血栓形成的佐剂治疗
6. A 59-Year-Old Woman with Extensive Deep Vein Thrombosis and Pulmonary Thromboembolism 7 Days Following a First Dose of the Pfizer-BioNTech BNT162b2 mRNA COVID-19 Vaccine [O] . Juhaina Salim Al-Maqbali, Sara Al Rasbi, Masoud Salim Kashoub, 2021

机译：一名59岁的女性具有广泛的深静脉血栓形成和肺血栓栓塞7天后的辉瑞 - Biontech BNT162B2 mRNA Covid-19疫苗后7天
7. Prophylaxis of deep-vein thrombosis after lower extremity amputation: Comparison of low molecular weight heparin with unfractionated heparin Profilaxia da trombose venosa profunda após amputação de membros inferiores: Comparação entre heparina de baixo peso molecular e heparina não fracionada [O] . Sidney Lastória, Hamilton A. Rollo, Winston Bonetti Yoshida, 2006

机译：预防下肢截肢后深静脉血栓形成：低分子肝素与普通肝素的预防比较预防下肢截肢后深静脉血栓形成：低分子肝素与普通肝素之间的比较

Progression of an Extensive Deep Vein Thrombosis under High Dose Therapy with low Molecular Weight Heparln of a 13-Year-OId Girl Suffering from Colitis Ulcerosa

摘要

著录项

相似文献

相关主题

期刊订阅